Residual renal function has been reported to be a major determinant of peritoneal dialysis (PD) technique survival for patients with end-stage kidney disease. Anuria leads to increases in PD prescriptions designed to maintain small solute clearances and ultrafiltration volumes, resulting in greater exposure to hypertonic glucose dialysates. We reviewed the effect of developing anuria in a cohort of 136 PD patients followed for a median of 12 months, to determine whether increasing exposure to higher glucose dialysates affected body composition by increasing body fat and reducing muscle mass. Despite increasing prescription of 22.7 and 38.6 g/l glucose dialysates there was no increase in body fat (31.1 ± 15.4 vs 30.9 ± 16.3 kg) or loss of fat-free weight (36.4 ± 12.1 vs 35.8 ± 12.3 kg). Changing PD prescriptions to maintain small solute clearances and ultrafiltration volumes did not lead to detrimental changes in body composition in the short term.
INTRODUCTION
More than 300 000 patients with end-stage kidney failure are treated by peritoneal dialysis (PD) worldwide. After peritonitis 1 loss of residual renal function and reliance on PD to achieve adequate ultrafiltration are the next most common causes of technique failure and transfer to haemodialysis. 2 Ultrafiltration in PD is achieved through an osmotic gradient created by using higher dextrose dialysate concentrations or an oncotic gradient using isomaltose (icodextrin)-containing dialysate. As such anuric peritoneal dialysate patients are typically prescribed more glucose-containing dialysates once residual renal function has been lost. It has been suggested that the increased mortality associated with loss of residual renal function may be due to protein energy wasting, secondary to increased glucose absorption from the peritoneal dialysates with loss of appetite and reduced protein intake. 3 To determine whether anuric PD patients develop protein energy wasting we determined changes in body composition in a cohort of patients using multi-frequency bioelectrical impedance assessments (MFBIAs).
PATIENTS AND METHODS
We compared the first MFBIA after patients were documented to have become anuric (urine output o 100 ml/day) with a follow-up assessment. One hundred thirty-six adult patients treated by PD under the care of two tertiary university hospitals at clinical dry weight between August 2008 and January 2012 were reviewed. All patients had MFBIAs performed in a standardised manner (BCM Fresenius, Bad Homberg, Germany; InBody 720, Seoul, South Korea) as part of established routine clinical care. 4, 5 We have previously derived equations comparing these devices, [5] [6] [7] and assessed the reproducibility of measuring fat mass (Bland Altman mean bias 0.04 kg). Although both Baxter (Baxter Health Care, Deerfield, IL, USA) and Fresenius PD systems were used, the majority were treated with Baxter PD systems.
Twenty-hour effluent peritoneal dialysate and urine collections were analysed to determine urine volume and both peritoneal clearances and residual renal function, and normalised nitrogen appearance to assess dietary protein intake calculated by standard methods, and all patients underwent peritoneal transport assessment.
Ethics approval was granted by the local ethics committee as audit and clinical service development.
Statistical analysis Statistical analysis was done by single or paired analysis, Student's t-tests, Mann-Whitney U-test or Wilcoxon paired analysis, with appropriate correction for multiple analyses, and by chi-square test with Yate's correction (GraphPad Prism version 6.0, San Diego, CA, USA). Data are presented as mean ± s.d., median (interquartile range) or percentage.
RESULTS
One hundred thirty-six patients, with a median age of 59.9 ± 14.3 years, of whom 54.4% were male, 35.3% diabetic, 31% Caucasoid, 36% South Asian and 27% African/Afro-Caribbean, were studied. The median PD vintage at the time that anuria was documented was 11.8 months (9.0-48.8), and the median time between assessments 11.8 (10-13) months. In all 36% were treated by continuous ambulatory PD and 64% by automated PD cyclers. On follow-up the percentage of patients prescribed icodextrin and higher dialysate glucose solutions increased from 44.1 to 63.9%; for the 22.7 g/l glucose (120 mmol/l) group it increased from 58 to 78.2% and for the ⩾ 38.6% glucose (204 mmol/l) group from 29 to 46% (all Po 0.05). Dialysis adequacy as assessed by weekly peritoneal urea clearance and ultrafiltration volumes did not differ (Table 1) , nor did dietary protein intake as assessed by normalised nitrogen appearance. Despite the increased prescription of higher glucose-containing dialysates (Figure 1 ), body composition measured by MFBIA did not change for the cohort (Table 1) or on subgroup analysis.
DISCUSSION
To compensate for the loss of residual renal function, PD prescriptions are typically adjusted in clinical practice to increase both peritoneal small solute clearances and ultrafiltration, leading to larger infill volumes and additional cycles, with greater use of hypertonic glucose dialysates. 3 In keeping with this practice there was a greater prescription of both hypertonic glucose dialysates and icodextrin in our cohort of anuric patients maintained on PD.
Previous reports have suggested that hunger profiles are blunted in PD patients compared with both haemodialysis patients and normal healthy controls, 8 as appetite may be reduced by a variety of factors, including abdominal distension from larger in-fill volumes and increased glucose absorption from hypertonic glucose dialysates. As such earlier studies reported reduced nutritional intake over time in anuric patients, 4 those patients with greater malnutrition, determined by subjective global assessment scoring, were more likely to die or transfer to haemodialysis. 3 Despite changes in PD prescriptions and exposure to greater amounts of dialysate glucose, our cohort of patients did not reduce their dietary protein intake, as assessed by normalised nitrogen appearance. We used MFBIA to determine body composition, as previous studies have shown a correlation with body composition measured by dual X-ray absorption scanning. 9 . Although increased dialysate glucose exposure could potentially lead to increased absorption leading to an increase in body fat, and a reduced appetite in combination with the uraemic state leads to protein energy wasting, 10 we observed no increase in body fat or reduction in muscle mass in this cohort of anuric PD patients followed for a median of a year.
Our data that show stable body composition over 12 months suggest that PD can be a successful therapy for chronic kidney failure patients despite a loss of residual renal function. Previous reports have suggested that PD adequacy, in terms of small solute clearances and ultrafiltration volumes, may be important in determining the failure of the PD technique. 2 However, studies have varied in small solute clearances and daily ultrafiltration volumes to be able to clearly define a minimum target for routine clinical practice. Our patients achieved acceptable targets for both small solute clearances and ultrafiltration volumes, 2 but lower levels may have resulted in protein energy wasting and technique failure. Our study was too small to identify an effect of age, sex, ethnicity and diabetes, and our cohort was also potentially biased as a survivor cohort, but even so, despite increasing exposure to higher glucose-based dialysates, we did not observe any detrimental changes to body composition, with patients maintaining both fat and muscle mass despite becoming anuric. Change in peritoneal dialysis prescription of 7.5% icodextrin, and 22.7 g/l and ⩾ 38.6 g/l glucose dialysates in peritoneal dialysis patients who had been recorded as being anuric, with a median peritoneal dialysis vintage of 11.8 months (9.0-48.8), and then received peritoneal dialysis prescription at the time of repeat bioimpedance after a median follow-up of 11.8 months. ***P o0.001.
